Rapport Therapeutics, Inc.·4

Sep 15, 4:05 PM ET

Huber Reid M 4

4 · Rapport Therapeutics, Inc. · Filed Sep 15, 2025

Insider Transaction Report

Form 4
Period: 2025-09-12
Huber Reid M
Director
Transactions
  • Purchase

    Common Stock

    2025-09-12$24.48/sh+20,400$499,37420,400 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $24.23 to $24.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4